Literature DB >> 1531294

Ondansetron in the control of refractory emesis following radiotherapy.

J T Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1531294     DOI： 10.1016/s0936-6555(05)80785-x

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  3 in total

Review 1.  Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.

Authors:  Petra Ch Feyer; Ernesto Maranzano; Alexander Molassiotis; Rebecca A Clark-Snow; Fausto Roila; David Warr; Ian Olver
Journal:  Support Care Cancer       Date:  2004-12-08       Impact factor: 3.603

Review 2.  A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.

Authors:  Kristopher Dennis; Rehana Jamani; Clare McGrath; Leila Makhani; Henry Lam; Patrick Bauer; Carlo De Angelis; Natalie Coburn; C Shun Wong; Edward Chow
Journal:  Support Care Cancer       Date:  2017-03-31       Impact factor: 3.603

3.  Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009.

Authors:  Petra Christine Feyer; Ernesto Maranzano; Alexander Molassiotis; Fausto Roila; Rebecca A Clark-Snow; Karin Jordan
Journal:  Support Care Cancer       Date:  2010-08-10       Impact factor: 3.603
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.